Study investigates value of 'center of excellence' designation

December 27, 2004

A new study says cancer surgery performed at a medical center designated by the National Cancer Institute (NCI) as a "center of excellence" is associated with less risk of death soon after surgery than if performed at a high-volume surgery center, but finds no difference in five-year survival rates. The full study will be published in the February 1, 2005 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society. This study was supported by grants from the NCI and the Agency for Healthcare Research and Quality (AHRQ).

In 1971 the NCI created a program to award cancer centers special designation as centers of regional excellence if they demonstrated excellence in three areas: research, cancer prevention, and clinical services. NCI cancer centers are well staffed with specialists, tend to have high procedure volumes, and better access to multidisciplinary consultation and the latest therapies--all reasons to believe they would have better outcomes than other cancer centers. Although these centers often advertise their superior outcomes, say the study's authors, to date their relative performance has not been examined.

Nancy J. O. Birkmeyer, Ph.D. from the Department of Surgery at the University of Michigan Medical School and her colleagues investigated whether this designation actually improves survival. The investigators reviewed data from 63,860 cancer patients who underwent cancer surgery. Patients treated at one of the 51 NCI cancer centers were compared to those from 51 control cancer centers with the highest volumes for each procedure.

Perioperative mortality was significantly lower at NCI-designated medical centers for four of six procedures: colectomy; pulmonary resection; gastrectomy; and esophagectomy. No significant difference in mortality was observed in patients treated with cystectomy or pancreatic resection at either type of institution.

Among patients surviving surgery, however, five-year survival rates for all six procedures did not differ significantly between NCI-designated cancer centers and control cancer centers for any of the procedures.

The authors conclude, "Our study suggests that NCI cancer center designation should be weighted less heavily than other factors in deciding where to undergo major cancer surgery." And they reassure patients who do not live near an NCI cancer center, saying they can optimize their odds after cancer surgery by selecting high-volume surgeons with sub-specialty training, which they should be able to find at high volume cancer centers close to home.
-end-
Article: "Do Cancer Centers Designated by the National Cancer Institute Have Better Surgical Outcomes?" Nancy J. O. Birkmeyer, Philip P. Goodney, Therese A. Stukel, Bruce E. Hillner, John D. Birkmeyer, CANCER; Published Online: December 27, 2004 (DOI: 10.1002/cncr.20785); Prints Issue Date: February 1, 2005.

Wiley

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.